Celecoxib (CXB), a selective cyclooxygenase-2 (COX-2) inhibitor, has been reported to mediate growth inhibitory effects, induce apoptosis, and reduce the risk for the occurrence and progression of several cancers, including GB [4–6]. This evidence concerns the gene PTGS2 and cancer.